Two-thirds of patients with poorly controlled type 2 diabetes have mostly asymptomatic yet abnormal gastric emptying, researchers report in the March issue of Clinical Gastroenterology and Hepatology. However, sustained improvements in glycemic control do not affect gastric emptying, the researchers found in a prospective study. Diabetes is associated with delayed

Gastric injections of botulinum toxin A (BTA) can delay gastric emptying but do not make obese individuals feel more full, alter their eating behaviors, or cause them to lose weight, according to the February issue of Clinical Gastroenterology and Hepatology. In attempts to help people lose weight, researchers have tested

Buspirone, an agonist of the serotonin receptor 5-HT1A, relaxes the proximal stomach to reduce symptoms of functional dyspepsia and increase gastric accommodation, according to trial results presented in the November issue of Clinical Gastroenterology and Hepatology. Functional dyspepsia is a common gastrointestinal disorder. It is characterized by early satiation, postprandial

About the Author

Dr. Kristine Novak is the science editor for Gastroenterology and Clinical Gastroenterology and Hepatology. She has worked as an editor at biomedical research journals and as a science writer for 15 years, covering advances in gastroenterology, hepatology, cancer, immunology, biotechnology, molecular genetics, and clinical trials. She has a PhD in cell biology and an interest in all areas of medical research.